Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||
| Net Income | -8,645 | -4,571 |
| Depreciation Amortization | 441 | 235 |
| Accounts receivable | -201 | -492 |
| Other Working Capital | -494 | -1,437 |
| Other Operating Activity | 5,917 | 1,158 |
| Operating Cash Flow | $-2,982 | $-5,107 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -36,718 | -5 |
| PPE Investments | -2,732 | -376 |
| Investing Cash Flow | $-39,450 | $-381 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | N/A | 51 |
| Debt Repayment | -105 | -73 |
| Common Stock Issued | 43,449 | 146 |
| Other Financing Activity | 4,093 | 7,800 |
| Financing Cash Flow | $47,437 | $7,924 |
| Beginning Cash Position | 2,471 | 35 |
| End Cash Position | 7,476 | 2,471 |
| Net Cash Flow | $5,005 | $2,436 |
| Free Cash Flow | ||
| Operating Cash Flow | -2,982 | -5,107 |
| Capital Expenditure | -2,732 | -376 |
| Free Cash Flow | -5,714 | -5,483 |